Keywords: Lung, Lung, COPD, Dual bronchodilator, treatment
Motivation: Bronchodilators relieve the symptoms of respiratory conditions, such as chronic obstructive lung disease (COPD). 3D PREFUL MRI offers a non-invasive assessment of pulmonary ventilation. It is unclear whether 3D PREFUL parameters are sensitive to ventilation changes induced by bronchodilators.
Goal(s): To determine whether 3D PREFUL parameters enable to measure response to dual bronchodilator therapy in COPD.
Approach: 3D PREFUL MRI and spirometry at baseline and 2 weeks after initiation of therapy.
Results: Ventilation assessed by 3D PREFUL parameters significantly improved by bronchodilator therapy. Relative changes of 3D PREFUL ventilation defect percentage parameters were similar to relative change differences of FEV1.
Impact: 3D PREFUL MRI derived ventilation maps show significantly reduced ventilation defects in COPD patients after bronchodilator therapy. This positions 3D PREFUL MRI as a promising candidate for non-invasive monitoring of regional ventilation changes in future clinical studies.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords